Description: ProSomnus is the first manufacturer of precision, mass-customized Precision Oral Appliance Therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus’ patented devices are a more comfortable and less invasive alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to more effective and patient-preferred outcomes. With more than 150,000 patients treated, ProSomnus’ devices are the most prescribed Precision Oral Appliance Therapy in the U.S.
Home Page: www.ProSomnus.com
OSA Technical Analysis
5860 West Las Positas Boulevard
Pleasanton,
CA
94588
United States
Phone:
844 537 5337
Officers
| Name | Title |
|---|---|
| Mr. Sung Kim | Co-Founder & CTO |
| Ms. Mindy Hungerman | Chief Financial Officer |
| Mr. Jerry Vogel | VP of Sales |
| Mr. Len Liptak | Co-Founder, CEO & Director |
| Dr. John E. Remmers M.D. | Chief Scientist |
| Ms. Heather Whalen | VP of Marketing Communications |
| Dr. Shouresh Charkhandeh D.D.S. | Global Scientific Committee Chair |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 4.3413 |
| IPO Date: | 2021-07-28 |
| Fiscal Year End: | December |
| Full Time Employees: | 95 |